- Total income
- ₹4,626 Cr
- Profit
- ₹267 Cr

IMCD
About IMCD
IMCD is a publicly listed company based in Rotterdam (Netherlands) founded in 1995, and was acquired by Abn Amro in July 2005. Speciality chemicals and food ingredients are distributed by IMCD. The company has 5,130 employees. IMCD has completed 52 acquisitions, including ACM AB, Addpol Chemspecialities and Andes Chem. Its chief executive, as recorded, is Piet Slikke. Its website imcdgroup.com draws about 46 thousand monthly visits. Its Indian entity Imcd India Private Limited reported revenue of βΉ2,155 Cr. IMCD offers products and services including Specialty Chemicals and Ingredients. Its focus areas include Food and Agriculture, Food Distributors and Multi Category.
Company details
IMCD was established in 1995 in Rotterdam, Netherlands, as a distributor in the chemicals and food sectors. Operations are centered on sourcing and supplying speciality chemicals and ingredients to industries worldwide. Services include market expertise, technical support, and logistics management. The company is headquartered in Rotterdam, with a global network supporting clients in Europe, Asia, and the Americas. Leadership is provided by CEO Piet Slikke.
IMCD is ranked #156 on the Fortune MNC 500 India (2026).
Recognitions & Rankings of IMCD
- Headquarters Rotterdam, Netherlands
- Employees 5,130
- Stage Public
- SectorsConsumer
- Website category Heavy Industry and Engineering · Chemical Industry
- Phoneβ’β’β’β’ β’β’β’β’
- Website imcdgroup.com
- Social LinkedIn X
- Acquired by Abn Amro (Jul 2005)
- Legal Name Imcd N.V.
Associated legal entities of IMCD
IMCD operates through Imcd India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Imcd India Private Limited CIN U51101MH2014PTC259765 | Active | 27 Nov 2014 | Mumbai, Maharashtra | ₹2,155 Cr | 262 | 3 | View details |
Products & Services of IMCD
IMCD offers a comprehensive portfolio of products and services, including Specialty Chemicals and Ingredients.
Specialty chemicals are distributed for use in industrial and manufacturing processes
Ingredients for food and pharmaceuticals are supplied through established networks
Funding Insights of IMCD
- Total Rounds 2
- First Round $94.87M
(May 2015)
All 2 funding rounds of IMCD with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2020 | Post-IPO | β | β | β | |
| May 2015 | $94.87M | Post-IPO | β | β | β |
1 investors in total: 1 institutional.
Investors in IMCD
IMCD has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ABN AMRO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
ABN AMRO is recognized as a personal bank in the digital era. | 1991 | abnamro.com | Amsterdam, Netherlands |
Investor details for IMCD
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Imcd India Private Limited (IMCD)
Imcd India Private Limited is the primary company behind IMCD. The board of Imcd India Private Limited currently have 2 directors; the longest-serving is Ramanuj Chandrashekhar Kankani, appointed in 2018. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramanuj Chandrashekhar Kankani DIN 08274950 | Director | 04 Dec 2018 | 7 yrs 11 mo | Imcd India Private Limited |
| Narendra Sujit Varde DIN 09026419 | Managing Director | 24 May 2023 | 3 yrs 5 mo | Imcd India Private Limited |
People of IMCD
57 people are tracked at IMCD (39 in leadership, 18 in team); the tracked headcount is 5,130.
| Name | Role | Group |
|---|---|---|
Piet Slikke | CEO | Leadership |
Daniela Bloomer | Head Of Marketing & Communications - Africa Region | Leadership |
Artem Kryukov | Finance & Operations Director, DACH & SEE | Leadership |
Nicky Huang | Managing Director IMCD China And IMCD Sanrise | Leadership |
Valerie Diele-Braun | CEO | Leadership |
Hans Kooijmans | CFO | Leadership |
Marcus Jordan | COO | Leadership |
Arturo Hoyo | Managing Director | Leadership |
| Managing Director | Leadership | |
Jagdish Kuchibhatla | Business Development Director - Biopharmaceuticals, APAC | Leadership |
Paul Hanbury | Managing Director IMCD UK | Director Home Care And I&i IMCD B.v. | Leadership |
Guido Smit | Group Supply Chain Head | Leadership |
Leidy Guerrero | Finance & Operations Director | Leadership |
Stan Bijsterveld | Global Operations Director | Leadership |
Pimsiraya Vichaidit | Business Group Director Coating & Construction, APAC | Leadership |
Alen Guy | Group Technical Excellence Director | Leadership |
Hugo Garcia | Business Director Food And Nutrition | Leadership |
Natasha de Lange | Managing Director | Leadership |
Tosca Holtland | Head Of Investor Relations | Leadership |
Eric Mitchell | Vice President Operations, US | Leadership |
37 more people are available in the full profile.
Complete people profiles for IMCD
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of IMCD
IMCD is a publicly listed company on the EURONEXT with ticker symbol IMCD in Netherlands, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Jun 2014
- Listed onEuronext: IMCD
- Listed entityIMCD N.V.
- Exchange sectorProcess industries
- ISINNL0010801007
- Share price105.35 EUR (+2.03% on the day) · 2026-10-14
- Market capitalisation6,093,606,297.00 EUR
- Price to earnings27.0
- EPS (diluted, trailing year)3.90 EUR
- Dividend yield1.75%
- Volume (last session)28,453
Financials of IMCD
Figures of Imcd India Private Limited, the primary company behind IMCD, for FY 2025. Revenue was ₹2,155 Cr (+17% year on year). Net profit was ₹267 Cr (6% margin). EBITDA was ₹657 Cr (15% margin). Revenue has grown at a compounded annual rate of +25% over three years and +50% over five years.
- ₹2,155 CrRevenue · FY 2025 · +17% YoY
- ₹267 CrNet profit · 6% margin
- ₹657 CrEBITDA · 15% margin
- ₹79.26 CrPaid-up capital
- 262Employees (provident fund records)
- +25%Revenue CAGR, 3 years
- +50%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 4.78B EUR | 217.6M EUR | 507.5M EUR |
| 2024 | 4.73B EUR | 278.2M EUR | 553.3M EUR |
| 2023 | 4.44B EUR | 292.3M EUR | 526.4M EUR |
| 2022 | 4.60B EUR | 313.1M EUR | 562.3M EUR |
| 2021 | 3.44B EUR | 207.3M EUR | 385.4M EUR |
Balance sheet, profit and loss, cash flow and ratios of Imcd India Private Limited are on its company page.
Detailed financial statements for IMCD
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IMCD
IMCD has strategically engaged in corporate development activities, having acquired 52 companies. Notable acquisitions include ACM AB, Addpol Chemspecialities and Andes Chem.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Specialty chemicals and intermediates are supplied to pharmaceutical manufacturers. | tricheminc.net | Mumbai, India | 1998 | Jun 2025 | β’β’β’β’ | |
Food ingredients are sourced and distributed to producers worldwide. | ferreralimentacion.com | 0 | Jun 2025 | β’β’β’β’ | ||
Food and nutraceutical ingredients are supplied to the food industry. | tecom.es | Spain | 1996 | May 2025 | β’β’β’β’ | |
Ingredient solutions for food, pharmaceuticals, and industries are supplied. | blumos.cl | Chile | 1947 | Oct 2024 | β’β’β’β’ | |
API manufacturing is specialized in by Selechimica as a CDMO. | 0 | Jun 2024 | β’β’β’β’ | |||
Manufacturing of pharmaceutical products is conducted by COBAPHARMA. | cobapharma.com | Barcelona, Spain | 2011 | Apr 2024 | β’β’β’β’ | |
Cosmetics and personal care ingredients are distributed in Benelux. | gova-benelux.com | Hoogerheide, Netherlands | 1999 | Mar 2024 | β’β’β’β’ | |
Provider of animal nutrition, refrigerants, industrial, and food products supplying services | bretano.com | Heredia, Costa Rica | 1961 | Mar 2024 | β’β’β’β’ | |
Company specializes in resins, additives, and pigments for use in inks, coatings, adhesives, and the construction industry | reschemtechnologies.com | Sydney, Australia | 2007 | Feb 2024 | β’β’β’β’ | |
Cosmetic, food, and industrial chemicals are distributed across South Asia. | valuetree.in | Mumbai, India | 2006 | Jan 2024 | β’β’β’β’ |
Complete acquisition details for IMCD
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of IMCD
15 dated milestones of IMCD across 30 years, from founding to its latest funding, stage changes and deals.
- Founded IMCD is founded.
- Exit Acquired by Abn Amro.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $94.9M.
- Funding Latest funding round, Post-IPO,.
- Acquisition Acquires ValueTree.
- Acquisition Acquires ResChem.
- Acquisition Acquires Bretano.
- Acquisition Acquires GOVA INGREDIENTS.
- Acquisition Acquires COBAPHARMA.
- Acquisition Acquires Selechimica.
- Acquisition Acquires Blumos.
- Acquisition Acquires Tecom Ingredients.
- Acquisition Acquires Ferreralimentacion.
- Acquisition Acquires Trichem Pharmascience.
Web traffic of IMCD
The website of IMCD (imcdgroup.com) receives about 46.1K visits a month and ranks #636,088 among all websites worldwide, #9,598 in Chemical Industry.
- Monthly visits46.1K
▼ 12% vs previous month
- Unique visitors20.9K
per month
- Global rank#636,088
among all websites
- Category rank#9,598
Heavy Industry and Engineering · Chemical Industry
- Bounce rate36%
- Pages per visit2.0
- Average visit32 sec
- DevicesDesktop 34% Β· Mobile 66%
Websites whose visitors overlap most with IMCD. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| azelis.com | 100% | 89.9K | #436,305 | View details | |
| caldic.com | 99% | 88.5K | #425,565 | View details | |
| thirumalaichemicals.com | 82% | 2.9K | #5,643,260 | View details | |
| calibrechem.com | 80% | 4.9K | #3,930,362 | View details | |
| makwater.com.au | 42% | 5.3K | #3,720,843 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 7 similar websites and full traffic analytics for IMCD
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Imcd
Complete news archive for IMCD
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IMCD
IMCD was founded in 1995 and raised its 1st funding round 20 years after it was founded.
IMCD is headquartered in Rotterdam, Netherlands. It is registered at Rotterdam, South Holland, Netherlands.
Piet Slikke is the CEO of IMCD, as recorded in our data.
IMCD has 5,130 employees.
The primary company behind IMCD, Imcd India Private Limited, reported revenue of βΉ2,155 Cr for FY 2025, up 17% year on year.
IMCD was established in 1995 in Rotterdam, Netherlands, as a distributor in the chemicals and food sectors. Operations are centered on sourcing and supplying speciality chemicals and ingredients to industries worldwide. Services include market expertise, technical support, and logistics management. The company is headquartered in Rotterdam, with a global network supporting clients in Europe, Asia, and the Americas. Leadership is provided by CEO Piet Slikke.
IMCD offers Specialty Chemicals and Ingredients.
Yes, IMCD is publicly traded on EURONEXT under the ticker symbol IMCD.
IMCD has made 52 acquisitions, including ACM AB, Addpol Chemspecialities, and Andes Chem.
IMCD has 1 investor. Key investors include ABN AMRO.
IMCD operates through Imcd India Private Limited.
Yes. IMCD was acquired by Abn Amro in July 2005.
